Results 11 to 20 of about 29,142 (301)

Exploratory Advanced Radiotherapies for Ameloblastoma and Ameloblastic Carcinoma-A Concise Review. [PDF]

open access: hybridOral Dis
ABSTRACT Objective Ameloblastoma is an aggressively growing odontogenic tumor with substantial management challenges and a high recurrence rate. Surgical resection is the treatment of choice for ameloblastoma, but adjuvant therapies like radiation have been explored in cases where surgery is not clinically advisable and the tumor is inoperable.
Turkstani H, Alfaifi A, Akintoye SO.
europepmc   +4 more sources

Epigenetic similarity between adenoid ameloblastoma and dentinogenic ghost cell tumour: DNA methylation analysis in odontogenic tumours. [PDF]

open access: yesJ Pathol Clin Res
Abstract Although adenoid ameloblastoma (AA) has recently been included in the WHO classification as a separate tumour type, its clinical, histological, immunohistochemical, and molecular similarities to dentinogenic ghost cell tumour (DGCT) raise questions about the current classification system. The aim of this study was to investigate the epigenetic
Oh KY.
europepmc   +2 more sources

Histopathological Spectrum of a Calcifying Odontogenic Cyst With Uncommon Findings. [PDF]

open access: yesCase Rep Dent
Calcifying odontogenic cyst (COC) is an uncommon lesion accounting for less than 1% of all odontogenic cysts. This pathology commonly affects the anterior jaw and is prevalent in the second to third decades of life, with no sex predilection. The lesion presents with a variable clinical and radiographic presentation, which can simulate other common jaw ...
Khadka S   +6 more
europepmc   +2 more sources

Mechanism and Potential Therapy in Ameloblastoma: Akt Signaling Pathway

open access: yesIndonesian Biomedical Journal, 2022
BACKGROUND: Ameloblastoma is the most common benign aggressive tumor. They are more prevalent in the mandible than in the maxilla, mostly observed on the posterior of the jaw.
Steward Hadi   +2 more
doaj   +1 more source

The Role of BRAF Inhibitors in the Management of Ameloblastoma: A Literature Review

open access: yesCureus, 2023
Ameloblastoma is one of the most prevalent but enigmatic benign odontogenic tumors of the jaw, accounting for approximately 10% of all maxillary and mandibular tumors.
Arindam Malakar   +5 more
semanticscholar   +1 more source

Ameloblastoma

open access: yesRevista da Faculdade de Odontologia de Porto Alegre, 2022
Estudo, sob o ponto de vista cIínico, radiológico e principalmente histopatológico, de casos de ameloblastoma, alguns dos quais foi feita ressecção e em outros não. Estudou-se também as tendências à recidiva.
João Jorge Diniz Barbachan   +1 more
openaire   +3 more sources

BRAF V600E Mutation in Ameloblastoma: A Systematic Review and Meta-Analysis

open access: yesCancers, 2022
Simple Summary Ameloblastoma is a benign odontogenic tumour, and the patient always presents at a later stage when the tumour is already in an aggressive state.
M. N. Mamat Yusof   +2 more
semanticscholar   +1 more source

Differential diagnosis of ameloblastoma and odontogenic keratocyst by machine learning of panoramic radiographs

open access: yesInternational Journal of Computer Assisted Radiology and Surgery, 2021
The differentiation of the ameloblastoma and odontogenic keratocyst directly affects the formulation of surgical plans, while the results of differential diagnosis by imaging alone are not satisfactory.
Zijia Liu   +6 more
semanticscholar   +1 more source

Recurrent Ameloblastoma: Clinical Manifestation and Disease-Free Survival Rate

open access: yesJournal of Oncology, 2022
Objectives Ameloblastoma is a slow-growing epithelial odontogenic neoplasm of the jaws with a high recurrence rate. The main treatment strategies for this lesion are radical or conservative surgical approaches. The aim of the present study was to analyze
Andrii Hresko   +6 more
semanticscholar   +1 more source

RAF1–MEK/ERK pathway‐dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation

open access: yesJournal of Pathology, 2021
Ameloblastoma is an odontogenic neoplasm characterized by slow intraosseous growth with progressive jaw resorption. Recent reports have revealed that ameloblastoma harbours an oncogenic BRAFV600E mutation with mitogen‐activated protein kinase (MAPK ...
S. Fujii   +13 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy